Lilly Ventures News Today

In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.

BioAge Labs, a biotech startup collaborating with Eli Lilly for trialing its obesity therapy, said on Tuesday it had raised $170 million in its latest funding round. The Richmond,...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Prior authorization, a fancy term for your doctor needing to gain approval from your health insurance company before doing a medical procedure, has typically been a heavily manual process involving lots of steps, reviews and people having to work together. Seeking approval from the insurance company is meant to prevent unnecessary procedures and keep healthcare costs down; however, the lengthy process of prior authorization often leads to delayed or even abandoned care. In an effort to fix thi...

/PRNewswire/ -- Ten63 announces the election of Steve Hall to its board of directors. Hall, who retired as a Partner at LV Management Group (Lilly Ventures)...

BASEL, Switzerland, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Noema Pharma, a Swiss-based clinical stage company targeting orphan central nervous system (CNS)...